Clinical Recommendation Summary: Arthrosamid vs Hyaluronic Acid for Knee Osteoarthritis

Background

Knee osteoarthritis (OA) is a prevalent, progressive joint disorder characterized by pain, stiffness, and reduced function. Intra-articular injections are a key non-surgical intervention for patients with persistent symptoms despite conservative management. Two options include hyaluronic acid (HA) and the newer Arthrosamid hydrogel.

Treatment Comparison

AspectHyaluronic Acid (HA)Arthrosamid Hydrogel
MechanismTemporary viscosupplementation
mimicking synovial fluid
Integrates into synovium to cushion and reduce inflammation
Onset of EffectWithin weeksWithin weeks
Duration of Effect6 monthsUp to 3 years (or more)
FrequencyOften requires repeat injectionsSingle injection
Pain ReductionModerate, short-termSustained, significant reduction (VAS scores)
Functional
Improvement
Modest improvement in mobility and stiffnessGreater improvement (WOMAC scores) sustained over 12
months
SafetyWell-tolerated, mild post-injection flaresWell-tolerated, minor swelling, low incidence of synovitis
Cost EffectivenessLower upfront cost, but may need multiple dosesHigher upfront cost, but potentially lower long-term cost

Clinical Recommendations

  • Use Arthrosamid in patients with moderate to severe knee OA who have not responded to HA or prefer long-term symptom relief without frequent reinjections.
  • Consider HA for patients preferring a more established, biodegradable option or those with mild OA needing short-term relief.
  • Both agents are suitable for patients contraindicated for or declining surgery.
  • Monitor for adverse events and counsel patients on expected onset and duration of effects.
  • Further real-world studies are encouraged to assess Arthrosamid’s long-term safety and cost-effectiveness.

Summary

Arthrosamid offers a promising, long-lasting alternative to hyaluronic acid for improving pain and function in knee OA. It may be preferred in patients seeking durable relief from a single injection.

Share the Post:

Relevant Articles

“Runner’s Trots”: The Real Medical Reason Endurance Athletes Sometimes Lose Bowel Control

What really happens when an elite athlete suddenly loses bowel control mid-race? The recent HYROX incident involving Australian athlete Joanna Wietrzyk put “runner’s trots” firmly in the spotlight — but exercise-induced diarrhoea, urgency and even faecal incontinence can happen to athletes at every level. During hard endurance exercise, blood is diverted away from the gut, repetitive impact can stimulate bowel activity, and heat, dehydration and pre-race nutrition can push the digestive system beyond its comfort zone. The result can be a sudden and sometimes very urgent need to go — with surprisingly little warning. So why does it happen, and can you prevent it? Here’s the real physiology behind one of endurance sport’s most awkward problems.

PRP for Knee Osteoarthritis: How Many Injections Do You Need, and How Long Does Relief Last?

If you're considering PRP for knee osteoarthritis, two of the biggest questions are how many injections are needed and how long the results may last. Recent research provides useful insight into both, with many clinical trials using a short course of 2–3 injections rather than a single treatment. Our latest evidence update looks at the durability of PRP, how platelet concentration may influence the length of benefit, and when a repeat course may be considered for patients who respond well.

Rotator Cuff Tendinopathy and PRP: Modest but Durable Benefit

Rotator cuff tendinopathy and partial-thickness tears are common causes of persistent shoulder pain, particularly when symptoms don't settle with rehabilitation alone. Research into PRP is growing, with recent trials suggesting its benefits may be modest but more durable over time compared with corticosteroid injections. Our latest evidence update explores the shoulder-specific research, including partial-thickness tears, injection technique and why precise targeting and a structured strengthening program remain important when considering PRP.